Alternatively, the differences in study protocols, such as BCG reagents, frequency and/or interval of BCG administration, and timing of tissue sampling, might have caused the discrepancy, because PD-L1 expression levels on tumor cells are known to dramatically change from time to time, depending on their microenvironment [6]. This evidence concerns the gene CD274 and neoplasm.